Skip to main content
Equibles

BLRX · BioLineRx Ltd. · Webcasts, Transcripts & Audio

Track BLRX — free

Use BLRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BLRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.32 -0.05 (-2.11%)
Rebalance outlook locked
Market Cap
$11.75M
Shares
4.98M
Volume · Oct 5 20.05K Avg daily vol (3M) 19.18K

BioLineRx Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for BioLineRx Ltd. (BLRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$18.55M '23 Q2 23-06-30 · $5.39M $484,000 '24 Q2 24-06-30 LATEST ▼94.4% $304,000 −$3.94M '25 Q2 25-06-30
Earnings call
FY26 · Q2
2026-08-31
BioLineRx Ltd. (BLRX) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-27
BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-23
BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
Confident tone GLIX1 joint venture for glioblastoma APHEXDA out-licensing / Ayrmid Pancreatic cancer (PDAC) / CheMo4METPANC trial
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript
Confident tone Pancreatic cancer (PDAC) CheMo4METPANC trial Motixafortide / APHEXDA commercial partnership with Ayrmid Pipeline expansion / in-licensing
Revenue
$304,000
▼ 94.4% YoY
Diluted EPS
$0.00
Gross margin
76.3%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
BioLineRx Ltd. (BLRX) Q1 2025 Earnings Call Transcript
Positive tone APHEXDA out-licensing and commercial performance Gloria Bio licensing agreement Pancreatic cancer (PDAC) CheMo4METPANC trial
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript
Confident tone Ayrmid/Gamida Cell licensing transaction PDAC / pancreatic cancer program Cost reduction and cash runway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript
Confident tone APHEXDA launch and formulary adoption Financial performance and revenue Sickle cell disease and gene therapy studies
Revenue
$5.39M
Diluted EPS
$0.00
Gross margin
83.4%
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript
Confident tone APHEXDA Commercial Launch Pancreatic Cancer Program (CheMo4METPANC) Gloria Biosciences Asia Partnership
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
BioLineRx Ltd. (BLRX) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
BioLineRx Ltd. (BLRX) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
BioLineRx Ltd. (BLRX) Q2 2023 Earnings Call Transcript
Revenue
$
Diluted EPS
$-0.80
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
BioLineRx Ltd. (BLRX) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
BioLineRx Ltd. (BLRX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
BioLineRx Ltd. (BLRX) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
BioLineRx Ltd. (BLRX) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
BioLineRx Ltd. (BLRX) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
BioLineRx Ltd. (BLRX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
BioLineRx Ltd. (BLRX) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
BioLineRx Ltd. (BLRX) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
BioLineRx Ltd. (BLRX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–21 of 21 webcasts
Key facts CIK 1498403 CUSIP 09071M304 Visit website Investor relations